Skip to content

DCOY DECOY THERAPEUTICS INC

Follow

COM (common), issuer CIK 1615219

4 managers (4 13F filers) reported a position in DCOY shares at 2026-06-30, 4,317 shares in all. 2 filers opened a position and 2 filers sold out during the quarter.

Managers
4
13F filers
4
New
2
Added
0
Reduced
2
Sold out
2
Shares held by filers
4,317

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
VANGUARD CAPITAL MANAGEMENT LLCin group VANGUARD GROUP INC4,034$29K<0.01%new13F-HRTimelineGroup
Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T…256$1.84K<0.01%-76513F-HRTimelineGroup
UBS Group AGin group UBS Group AG25$180<0.01%-52113F-HRTimelineGroup
Caitong International Asset Management …2$14<0.01%new13F-HRTimeline

Events

  • CVI Investments, Inc. and 1 other reporting person reported 72,717 DCOY shares, 9.9% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001649553-26-000138

    Accepted , ingested